Market Signal Briefing

Syndax Pharmaceuticals, Inc. (SNDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

MP Materials Corp. (MP) 2nd Annual CG Virtual Sustainability Summit March 12, 2026 12:30 PM EDT

Company Participants

Ryan Corbett - Chief Financial Officer

Conference Call Participants

George Gianarikas - Canaccord Genuity Corp., Research Division

Presentation

George Gianarikas
Canaccord Genuity Corp., Research Division

Hi, everyone. I'm George Gianarikas, one of Canaccord Genuity's sustainability analysts. And we're blessed to have with us today, Ryan Corbett, CFO of MP Materials. Ryan, thank you so much for joining.

Ryan Corbett
Chief Financial Officer

Thanks so much for having me, George. Appreciate it.

Question-and-Answer Session

George Gianarikas
Canaccord Genuity Corp., Research Division

Maybe to start, if you could give us a high-level overview of Q4 and any highlights you wanted to share?

Ryan Corbett
Chief Financial Officer

Sure. Yes, happy to do it. Obviously, we reported a couple of weeks ago, maybe it was last week, I'm losing track. But I think the story for Q4 was continued strong execution from the team. As you all saw, we continue to ramp both in the Materials segment and Magnetics segment very, very rapidly. We exited the year in the Materials segment at nearly a 4,000-ton production run rate. We produced our first commercial magnets to customer specifications on our commercial equipment down Independence, where I'm actually sitting right now.

And I think what we've seen over the last several months, and it's continuing and frankly, accelerating is real customer engagement across all parts of the business. And so we came out of Q4 and into Q1 with a tremendous amount of momentum. I think the other thing that is particularly exciting from a financial perspective is you saw a strong return to profitability in the business, which we expect to continue and really be enhanced with the market pricing environment that we're seeing. And our expectation is that's just going to

HomeMarket OutlookToday's Market

SummaryAfter three years of actual returns for the S&P 500, it would be safe to assume that just a “reversion to the mean” type year for the S&P 500 would be single digits, either mildly negative or mildly positive.Iran has changed the 2026 investment landscape entirely, and has tossed a wrench into the “rotational” trade that made sense, at least until the air strikes.The “Liberation Day” correction that happened from late January ’25 through early April ’25 saw a 20% peak-to-trough correction. da-kuk/E+ via Getty Images

This blog post was written in late December ’25 just to think through the various variables impacting equity market returns, but one of the easier ways to analyze historical market returns is to just assume that double-digit

11.18K Followers

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that it intends to complete a non-brokered private placement financing (the "Offering") of up to 5,000,000 units (the "Units"), at a price of $0.05 per Unit for gross proceeds of $250,000 (the "Private Placement") subject to acceptance by the TSX Venture Exchange. Each Unit consists of one common share (a "Share") and one transferable common share purchase warrant (a "Warrant") of the Company. Each Warrant entitles the holder to acquire one additional common share of the Company at an exercise price of $0.06 for a period of three years from issuance. The gross proceeds will be used for general corporate purposes and ongoing working capital.

The Private Placement is subject to TSX Venture Exchange approval. All Shares issued pursuant to the Private Placement and any Shares issued upon exercise of the Warrants will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities laws and the policies of the TSX Venture Exchange.

No finder's fees are payable in connection with the Private Placement.

It is anticipated that an insider of the Company, John Lee (the "Insider"), will subscribe for up to 4,000,000 Units for gross proceeds of $200,000. The issuance of Units to the Insider is considered a related party transaction within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company intends to rely on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 pursuant to sections 5.5(a) and 5.7(1)(a) as the fair market value of the Insider's participation in the Private Placement does not exceed 25% of the Company's market capitalization. The Private Placement will not result in the creation of a new control person of the Company and the Company is not aware of any undisclosed material information.

About Oracle Commodity Holding Corp.

Oracle Commodity Holding Corp. is a mining royalty company holding royalties on several precious metal and critical mineral mining projects.

Further information on Oracle Commodity can be found at www.oracleholding.com.

ORACLE COMMODITY HOLDING CORP.

ON BEHALF OF THE BOARD
"Jason Powell"
CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this news release, including statements which may contain words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", or similar expressions, and statements related to matters which are not historical facts, are forward-looking information within the meaning of applicable securities laws. Such forward-looking statements, which reflect management's expectations regarding Oracle's future growth, results of operations, performance, business prospects and opportunities, are based on certain factors and assumptions and involve known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements.

Forward-looking statements involve significant risks and uncertainties, and should not be read as guarantees of future performance, events or results, and may not be indicative of whether such events or results will actually be achieved. A number of risks and other factors could cause actual results to differ materially from expected results discussed in the forward-looking statements, including but not limited to: market conditions and investor sentiment; changes in business plans; ability to secure sufficient financing to advance the Company's investment business; and general market and economic conditions. Additional risk factors are set out in the Company's latest annual and interim management's discussion and analysis, available on SEDAR at www.sedarplus.ca.

Forward-looking statements are based on reasonable assumptions by management as of the date of this news release, and there can be no assurance that actual results will be consistent with any forward-looking statements included herein. Readers are cautioned that all forward- looking statements in this news release are made as of the date of this news release. The Company undertakes no obligation to update or revise any forward-looking statements in this news release to reflect circumstances or events that occur after the date of this news release, except as required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288313

Source: Oracle Commodity Holding Corp.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of agilon health, inc. (NYSE: AGL) breached their fiduciary duties to shareholders.

If you currently own agilon stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Key Takeaways EQIX launched Distributed AI Hub to help enterprises connect, secure and simplify complex AI ecosystems.Hub links model firms, GPU clouds, data platforms and security services via private low-latency connectivity.Equinix enables consistent AI infrastructure across clouds, edge and data centers at 280 global sites. Equinix, Inc. (EQIX - Free Report) launched the Distributed AI Hub, powered by Equinix Fabric Intelligence, to help enterprises connect, secure and simplify their increasingly complex and distributed AI ecosystems.

The Hub serves as a neutral location where enterprises can discover, connect to, and access AI infrastructure providers — such as model companies, GPU clouds, data platforms, network and security services, and AI frameworks — via private, low-latency connectivity across Equinix's data centers.

To get the most from agentic AI, enterprises must unify distributed workflows: training data and inference workloads spread across public clouds, private data centers, edge environments, and a rising wave of specialized neoclouds. Each has its unique performance and sovereignty constraints. This maze of silos slows innovation, complicates governance and makes it hard to run AI workloads close to the data that fuels them, limiting business impact and user experience.

That’s why Equinix is advancing distributed AI infrastructure through the new Distributed AI Hub, offering enterprises a simple, secure, and high-performance solution for running AI workloads across multiple locations.

The Hub provides a unified, vendor-neutral framework that seamlessly integrates data, compute, cloud platforms and AI ecosystem partners. It lets enterprises execute AI workloads where they perform best without rebuilding their architecture each time or moving data to different locations. The Hub offers a simple, secure way to connect models, move data, run inference, and manage distributed AI systems with consistent governance and control. In contrast to hyperscaler AI marketplaces that prioritize their own offerings, this Hub stays truly open, empowering customers to build a custom AI stack from best-of-breed providers.

Enterprises can now deploy consistent AI infrastructure patterns worldwide through the Distributed AI Hub, accessible at all 280 Equinix data centers globally.

In the past three months, shares of this Zacks Rank #2 (Buy) company have increased 27.1%, outperforming the real estate market’s 2.2%.

Image Source: Zacks Investment Research

Other Stocks to ConsiderSome other top-ranked stocks from the broader REIT sector are Cousins Properties (CUZ - Free Report) and Gladstone (LAND - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for CUZ’s 2026 FFO per share is pegged at $2.93, suggesting a 3.2% increase year over year.

The Zacks Consensus Estimate for LAND’s 2026 FFO per share is pegged at 43 cents, calling for a rise of 10.3% year over year.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

Lifetime Brands, Inc. (LCUT) Q4 2025 Earnings Call March 12, 2026 11:00 AM EDT

Company Participants

Robert Kay - CEO & Director
Laurence Winoker - Executive VP, Treasurer & CFO

Conference Call Participants

Matthew Koranda - ROTH Capital Partners, LLC
Brian McNamara - Canaccord Genuity Corp., Research Division
Anthony Lebiedzinski - Sidoti & Company, LLC

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Lifetime Brands Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please also note today's event is being recorded.

At this time, I'd like to introduce our host for today's conference, [ Jamie Kirchen ]. Mr. Kirchen, you may go ahead.

Unknown Executive

Good morning, and thank you for joining Lifetime Brands Fourth Quarter 2025 Earnings Call. With us today from management are Rob Kay, Chief Executive Officer; and Larry Winoker, Chief Financial Officer.

Before we begin the call, I'd like to remind you that our remarks this morning may contain forward-looking statements that relate to the future of the company, and these statements are intended to qualify for the safe harbor protection from liability established by the Private Securities Litigation Reform Act. Any such statements are not guarantees of future performance and factors that could influence our results are highlighted in our earnings release and other factors are contained in our filings with the Securities and Exchange Commission. Such statements are based upon information available to the company as of the date hereof and are subject to change for future developments. Except as required by law, the company does not undertake any obligation to update such statements.

Our remarks this morning and in our earnings release also contain non-GAAP financial measures within the meaning of Regulation G promulgated by the Securities and Exchange Commission. Included in such release is a reconciliation of these non-GAAP financial

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© Jeff Swensen / Getty Images News via Getty Images

American Airlines Group (NASDAQ:AAL) shares slipped 4% in Thursday trading, falling below $11 as a perfect storm of macro fears, surging oil prices, and company-specific news lands all at once. The broader airline sector is getting hit hard today, but American is absorbing the most punishment.

The S&P 500 also headed lower as stagflation fears return to the forefront. Airlines are a high-beta expression of economic confidence, and right now that confidence is eroding.

The sector-wide pressure is real and measurable. Southwest Airlines (NYSE:LUV) stock is actually the hardest hit today, down 6% while United Airlines Holdings (NASDAQ:UAL) stock is off 4%. Meanwhile, Delta Air Lines (NYSE:DAL) stock is relatively resilient as it’s down only 2%. For more on Delta and Wall Street’s perspective, see Delta Air Lines’ analyst outlook and price target analysis.

Oil Prices Are the Sector’s Biggest Enemy Right Now WTI crude oil surpassed $94 per barrel Thursday afternoon, up sharply from roughly $71 per barrel on March 2. That kind of move in under two weeks is a direct gut punch to airline operating margins. Crude oil temporarily topped $100 per barrel following new Gulf shipping attacks, and the market is pricing in sustained elevated fuel costs.

Barron’s reported on March 10 that airline stocks are “at the mercy of oil prices” following the Iran war onset, with UBS analysts suggesting only three airlines may be able to turn a profit under current oil price conditions. That framing is brutal for American Airlines specifically. Unlike competitors such as Delta, American Airlines made the decision not to hedge its fuel prices, leaving it fully exposed to every dollar of upside in crude.

Consumer confidence isn’t helping, either. The University of Michigan Consumer Sentiment index sits at 56.4 as of January 2026, deep in pessimistic territory and well below the 80-point neutral threshold. Discretionary travel is historically one of the first line items consumers cut when they feel financially squeezed.

American Airlines Gets a Downgrade and a Labor Headache Evercore ISI Group analyst Duane Pfennigwerth maintained his “In-Line” rating on American Airlines shares today but lowered his price target from $17 to $14, a cut of roughly 18%. The consensus from 21 analysts still implies meaningful upside from current levels, but the direction of estimate revisions is clearly downward. The average target price from those 21 analysts implies 55.26% upside from the current price, though that gap reflects uncertainty as much as opportunity.

The Association of Professional Flight Attendants has reintroduced “WAR” (We Are Ready) regalia, including red ID lanyards and pin badges, following a no-confidence vote in CEO Robert Isom last month. The Allied Pilots Association has also been vocal about its frustrations. This is significant as labor unrest at an airline is an operational risk that can translate directly into cancellations, delays, and reputational damage.

American Airlines profits fell to $111 million in 2025, down 87% from the prior year, while Delta and United posted dramatically stronger results. The Q4 2025 adjusted EPS came in at $0.16 against a $0.35 estimate, and Winter Storm Fern caused over 9,000 flight cancellations with an estimated $150 to $200 million revenue impact in Q1 2026. American Airlines also ranked tied for last place in the Wall Street Journal‘s latest U.S. airline rankings.

The Bull Case Hasn’t Disappeared Still, Susquehanna upgraded American Airlines to “Positive” with a $20 price target in January, citing demand recovery through 2027. The company is also investing heavily in its premium product, including new Flagship Suites and the Airbus A321XLR, and is targeting a 200-strong international fleet by 2030.

Moreover, a new AI-powered connection-holding system is expanding across major hubs. Also, a DFW hub restructuring rolling out in April 2026 is designed to improve operational resilience.

In any case, American Airlines’ Q1 2026 guidance calls for revenue growth of 7% to 10% year over year, and management has projected full-year 2026 free cash flow above $2 billion, per company guidance. The operational turnaround story is intact on paper; the problem is that macro headwinds and structural vulnerabilities are making it very hard for the market to give American Airlines the benefit of the doubt right now.

American Airlines stock is down nearly 31% year-to-date, making the turnaround thesis a high-conviction bet rather than a safe harbor. Today’s selloff layers a fresh analyst cut, a labor escalation, and a crude oil spike onto a stock that was already struggling, reflecting the ongoing challenges facing the carrier amid today’s broader market pressure.

HomeDividends AnalysisDividend Quick Picks

SummaryTop ten large cap value (GASV) stocks are forecasted to deliver an average 38.12% net gain by mid-March 2027, with yields up to 13.03%.Analyst targets suggest the five lowest-priced, highest-yield GASV stocks could outperform, offering an 18.5% higher gain than the top ten as a group.Fourteen of twenty-nine 'safer' lowest-priced GASV stocks are currently buyable, with seven meeting the ideal dividend-to-price criteria for fair value.Seventeen of seventy GASV stocks show negative free cash flow margins, signaling caution as dividends are paid from borrowed money.Large Cap Value rankings from YCharts identified stocks with low prices relative to their assets and profits. Ben Graham Formula strategy selected stable stocks with strong earnings and dividends based on Graham's book "The Intelligent Investor.”.Looking for a portfolio of ideas like this one? Members of The Dividend Dog Catcher get exclusive access to our subscriber-only portfolios. Learn More » iridi/iStock via Getty Images

Foreword About Large Cap Value “A Value ranking for large cap stocks from YCharts puts together complementary strategies found during their stock research. The value ranking looks at the price of a stock relative to a number of measurements that determine

31.44K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of T either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Scan QR code to install app

Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.

HomeStock IdeasQuick Picks & Lists

SummaryThe Touchstone Large Cap Fund (Class A Shares, Load Waived) underperformed its benchmark, the Russell 1000® Index, for the quarter ended December 31, 2025.The underperformance of the Quality factor, which the Fund tilts toward, was a headwind to relative performance this quarter.An underweight to both Information Technology and Real Estate aided performance, while an underweight Health Care and overweight Financials detracted from performance. ilkercelik/E+ via Getty Images

The following segment was excerpted from the Touchstone Large Cap Fund Q4 2025 Commentary.

Portfolio Review The Touchstone Large Cap Fund (Class A Shares, Load Waived) underperformed its benchmark, the Russell 1000® Index, for the quarter ended December 31, 2025.

14 Followers

Swire Pacific Limited (SWRAY) Q4 2025 Earnings Call March 12, 2026 5:45 AM EDT

Company Participants

Guy Martin Coutts Bradley - Executive Chairman of the Board
Martin James Murray - Finance Director & Executive Director
Karen So - Managing Director of Swire Coca-Cola
Cindy Cheung - Manager Group Public Affairs

Conference Call Participants

Wai Ming Liu - HSBC Global Investment Research
John Lam - UBS Investment Bank, Research Division
Simon Cheung - Goldman Sachs Group, Inc., Research Division

Presentation

Guy Martin Coutts Bradley
Executive Chairman of the Board

Good evening, everybody, and thank you for joining us. Let's get straight in, and I'll start with the strategic highlights. I think you can see that we've basically been delivering across the business on our growth strategy in each of the different core businesses under the Swire Pacific name.

On property, we've got a very healthy pipeline of new projects on the way. We continue to do effective capital recycling of noncore assets. Importantly, for us, we're continuing to invest in the Greater Bay Area, which is a stated objective of the property team. And we're very pleased last year to launch our first residential project successfully, I would say, in Shanghai in the Chinese Mainland. So property is very much on strategy and continuing to deliver good growth.

Beverages, it's been a tough year in 2025 in terms of the environment. But I think you can see the resilience of the beverage business for us. We continue to invest through the cycle here, and that investment has been in new plants and new equipment in both the Chinese Mainland and in Vietnam so far. And we continue to try to integrate the new Southeast Asian franchises that we've successfully acquired over the last few years, specifically Vietnam and Thailand.

On the aviation front, the story has

Philadelphia, Pennsylvania--(Newsfile Corp. - March 12, 2026) - Kaskela Law LLC announces that it is investigating Reservoir Media, nc. (NASDAQ: RSVR) on behalf of the company's long-term shareholders.

Click here to receive additional information about this investigation: https://kaskelalaw.com/case/reservoir-media/

The investigation seeks to determine whether Reservoir Media and/or the company's representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.

Reservoir Media shareholders are encouraged to promptly contact lead investigative attorney Adrienne Bell, Esquire at (484) 229 - 0750 or by email at [email protected]. Investors can also request more information about this investigation by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/reservoir-media/

ABOUT THE FIRM:

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC, including the firm's recent monetary recoveries for aggrieved investors in merger & acquisition litigation, please visit our website (www.kaskelalaw.com) or contact us today at (888) 715 - 1740.

This communication may constitute attorney advertising in certain jurisdictions.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288295

Source: Kaskela Law LLC

Close-up of logo for investment management app Robinhood on paper, against a light wooden surface, April 21, 2019. (Photo by Smith Collection/Gado/Getty Images)

Getty Images

Investing in stocks means embracing volatility as a cost of long-term growth. Among the 5 significant systemic shocks during which Robinhood Markets (HOOD) was traded, the stock experienced an average drawdown of -37%. For reference, the S&P 500 had an average -13% decline in those same instances.

If you hold an investment in HOOD stock, you might wonder: if the macroeconomic climate deteriorates, what is the maximum potential loss for this stock?

The response is wholly contingent on the crisis's transmission mechanism. Not every market shock is the same. To appropriately assess the risk, it is essential to ascertain how HOOD reacts to varying types of systemic stress.

What Is The Stock’s Most Significant Vulnerability?

When analyzing these past crashes by their underlying causes, a distinct pattern appears: HOOD confronts its most serious structural challenges during ‘Rate & Valuation Shock’ scenarios. Although broader market equities feel the impact of such conditions, HOOD has historically encountered disproportionate declines when this mechanism is activated. In such situations, the stock has typically recorded a -50% decline.

To grasp the inherent risk associated with this stock, here is exactly how it performed during its most challenging assessments across three different macroeconomic landscapes.

How Does It Respond To A Rate & Valuation Shock?

2022 Fed Tightening Inflation Bear Market (Jan 2022 to Oct 2022)

The CPI surged to 9.1%, prompting aggressive tightening measures since Volcker. Russia’s invasion of Ukraine further escalated global energy and food prices.

MORE FOR YOU

Stocks and bonds declined concurrently, nullifying the traditional 60/40 hedge. Rising interest rates adversely affected long-duration assets until CPI fell in October 2022.

HOOD stock performance compared to other assets: The stock dropped -63%, while the S&P fell -24% and bonds experienced a -35% fluctuation.

What Occurs During A Sovereign & Geopolitical Risk Concern?

2025 U.S. Tariff Shock (Feb 2025 to Jun 2025)

The Trump administration declared 145% tariffs on Chinese imports on April 2, 2025, marking the most aggressive trade move since the 1930s.

Equities and the dollar plummeted simultaneously, indicating diminished confidence. Supply chain ruptures and small-cap input inflation led to widespread declines, impacting nearly all sectors.

HOOD stock performance compared to other assets: The stock declined -42%, while the S&P saw a -19% drop and bonds recorded a -3.8% change.

Can It Withstand A Positioning & Commodity Unwind Crisis?

2024 Yen Carry Trade Unwind (Jul 2024 to Aug 2024)

The BOJ’s rate hike on July 31, 2024, triggered yen appreciation, dismantling carry trade profitability. Subsequently, a disappointing U.S. jobs report heightened recession fears.

The Nikkei plummeted by 12.4% on August 5. Tech stocks were hit hardest before the BOJ eased its signals, proving recession fears to be premature.

HOOD stock performance compared to other assets: The stock decreased -26%, while the S&P experienced a -7.8% dip and bonds showed a -1.2% movement.

Summary of Past Market Shock Drawdowns for HOOD

HOOD

Trefis

What Can You Do For Your Investments?

Ultimately, enduring a market crash necessitates comprehension of what undermines your specific investments. For HOOD, the kryptonite is evidently Rate & Valuation Shock. By scaling your holdings with these particular drawdowns in consideration, you can entirely eliminate emotion from the decision-making process.

Implementing objective and rule-based portfolio management is the most effective strategy to safeguard capital when the macro environment inevitably breaks down again. Trefis High Quality Portfolio is structured with these principles in mind and has achieved a return of over 105% since its inception.

Lucid unveiled a two-seater robotaxi concept without steering wheel and pedals, and launched new self-driving tech subscriptions, as the electric-vehicle maker laid out its roadmap for the technologies at an investor day event on Thursday.

The unveiling deepens Lucid’s push into fully autonomous vehicles, potentially putting it in direct competition with Tesla’s Cybercab as automakers race to build a driverless future.

The Elon Musk-led company last month said its first Cybercab had officially rolled off the production line at its Gigafactory in Texas.

Lucid unveiled a two-seater robotaxi concept without steering wheel and pedals. REUTERS Tesla expects to begin mass production of Cybercab in April.

Lucid said its two-seater robotaxi will have 40% lower operating cost and would have an efficiency figure of around 5.5 miles per kilowatt hour.

The company did not provide more details on timeline or pricing.

The company is taking a dual-pronged approach, partnering with other firms for robotaxis, while selling EVs with similar self-driving capabilities.

The company has also partnered with Uber and Nuro to commercialize a robotaxi based on its Gravity SUVs this year.

Lucid, known for its luxury Air sedans, is also racing to launch a more affordable mid-size EV platform to broaden its customer base.

Lucid said its two-seater robotaxi will have 40% lower operating cost and would have an efficiency figure of around 5.5 miles per kilowatt hour. Marc Winterhoff, interim CEO, right, with Uber President Andrew Macdonald. REUTERS Monthly subscription starts at $69 Lucid’s monthly subscription for its self-driving technology would be priced between $69 and $199 depending on the level of autonomous driving capability a customer chooses, the EV maker said.

Bigger rivals Rivian and Tesla have also shifted to subscription-based systems in recent months, reflecting automakers’ increasing focus on diversifying their businesses to software and recurring revenue streams.

Last month, Tesla shifted to a subscription plan for Full Self-Driving at $99, with its vehicle owners no longer being able to purchase the feature as a one-time, permanent option.

The unveiling deepens Lucid’s push into fully autonomous vehicles, potentially putting it in direct competition with Tesla’s Cybercab as automakers race to build a driverless future. REUTERS

Lucid also said it would launch a monthly subscription for its self-driving technology for its EVs. REUTERS Musk has since said the $99 monthly price will rise “as FSD’s capabilities improve.”

Rivian launched its in-house driver assistance system, Autonomy+, at $49.99 per month or $2,500 as a one-time purchase, undercutting Tesla’s pricing.

For months, investors have watched Nike, Inc. NYSE: NKE, a titan of the consumer discretionary world, struggle to find its footing, testing the patience of even its most loyal shareholders. The stock's persistent underperformance has been a key storyline. But a catalyst just sent a powerful signal through the market: a decisive Overweight upgrade from Barclays has injected a fresh wave of optimism, suggesting the tide may finally be turning. This external validation aligns perfectly with the internal message from CEO Elliott Hill, who recently framed Nike's situation as the middle innings of a comeback, positioning Nike as a company in the midst of executing a strategic recovery, not just starting to address its problems.

Get NIKE alerts:

The Comeback's Home-Field Advantage Before a global comeback can take hold, a company must first win at home. For Nike, the latest financial results from its North American segment provide compelling evidence that its turnaround strategy is not just a plan, but a reality. The region posted an impressive 9% revenue growth in the second quarter. This figure is made even more significant by the engine that drove it: a 24% increase in its wholesale business.

NIKE Today

$54.46 -1.24 (-2.22%)

As of 01:38 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$52.28▼

$80.17Dividend Yield3.01%

P/E Ratio32.04

Price Target$74.90

This isn’t just a trivial data point; for investors, it is a crucial indicator that Nike's recovery has a solid foundation. This growth represents a major strategic pivot, a channel reset away from the previous, more aggressive direct-to-consumer focus. By re-engaging key retail partners, Nike is showing it can more effectively manage inventory and reach a broader customer base. 

Strong wholesale growth signifies that the painful period of inventory glut is largely over. Partners are not only clearing out old products but are now confidently placing larger orders for new ones.

This renewed confidence is a forward-looking signal, further reinforced by management’s commentary on an improving order book for the upcoming spring and summer seasons.

This operational success is translating directly into financial health. With less excess inventory to clear, Nike is seeing fewer days of promotion and increased demand at full price. For investors, this is the critical link. A healthy wholesale channel combined with strong consumer demand at full price is the primary formula for sustainable revenue growth and, importantly, the recovery of gross margins.

From Inventory Cleanup to Innovation Rollout With its retail channels now clean and ready for new products, the focus shifts to what will drive the next phase of growth. Nike's answer lies in its Sport Offense, a strategic framework designed to accelerate a relentless flow of athlete-centered innovation to the marketplace. Nike is now prepared to fill its partners' shelves with the kind of exciting, high-margin products that originally built its empire.

The initial results of this renewed focus are already clear and compelling.

Running on All Cylinders: The performance running category, a core segment for the brand, has grown by over 20% for two consecutive quarters. This is more than growth; it signifies that Nike is taking back market share with a consistent flow of newness. Products like the Structure 26, a new stability shoe designed to provide runners with enhanced support, are resonating strongly. Apparel's Next Advance: Nike is set to debut its new AeroFit platform, described as air conditioning for the body, in its national team kits. This commitment to bringing tangible performance technology to a massive global audience for the World Cup is a classic Nike move. Basketball Bounces Back: Consumer excitement is returning to the basketball category, with strong sell-through for signature shoes and a positive reception for new launches like the GT Future, creating buzz and driving traffic to retailers. Perhaps the most definitive proof of this renewed product strength comes from Nike's partners. Bookings for the upcoming World Cup are up nearly 40% compared to the 2022 event, a powerful testament to the confidence retailers have in the new product lineup. For investors, the takeaway is clear: Nike is shifting from selling more to selling better, a strategy that directly supports a recovery in profitability.

Taking the Winning Formula Global While North America provides the blueprint, investors are rightly focused on the well-publicized headwinds in other areas, particularly Greater China and the Converse brand. However, these challenges should be viewed not as roadblocks, but as the next phase of a now-proven turnaround strategy. Management has acknowledged the difficult results from Greater China, where revenue fell 17%, but has responded with an actionable plan. This includes a new leadership structure with the region reporting directly to the CEO for faster decision-making, strategic investments in key city retail, and a crucial pivot back to an innovation-led, premium brand identity rather than competing on price.

The pressure on gross margins has also been a key concern. Yet, a critical insight from CFO Matthew Friend reframes the entire narrative. He noted that, excluding the external impact of tariffs, Nike's underlying gross margins are already on an expansion path. This indicates that the core business is fundamentally healing and that profitability is improving as Nike executes its plan.

A Discount on a Blue-Chip Rebound The final piece of the investment puzzle is valuation. Nike's stock price has faced a difficult stretch, trading down approximately 12% year-to-date and down 25% over the past year. This underperformance, driven largely by the now-addressed inventory issues and the known challenges in China, has created what many analysts see as an attractive entry point.

NIKE Stock Forecast Today12-Month Stock Price Forecast:
$74.90
37.46% Upside

Moderate Buy
Based on 35 Analyst Ratings

Current Price$54.49High Forecast$110.00Average Forecast$74.90Low Forecast$35.00NIKE Stock Forecast Details

The current Wall Street consensus price target for Nike is $74.90, representing a potential upside of more than 30% from its current levels. Looking at the forward price-to-earnings ratio (P/E) of 27.33, the stock is trading at a valuation that anticipates a significant earnings rebound.

The argument is straightforward: the market has already priced in the negative news from the Converse reset and the multi-quarter timeline for the China recovery. Therefore, as the North American recovery continues and any signs of stabilization emerge from its international segments, there is a powerful catalyst for the stock to re-rate higher as the market begins to price in the success of the turnaround.

Lacing Up for the Next Leg of Growth The Barclays upgrade appears to be more than just a fleeting positive headline; it is an external validation of an internal reality that is starting to show up in the numbers. For Nike, the North American business provides clear proof of concept. A rejuvenated innovation pipeline is supplying the fuel, and the stock's current valuation may present an opportunity. 

While the full, global turnaround remains in its middle innings, the most critical phase, the successful reset of its core market, is now largely complete. For investors, the next major checkpoint will be Nike’s third-quarter earnings report on March 31, where continued margin improvement and any signs of stabilization in China will be key indicators that this comeback is not only on track but finally hitting its stride.

Should You Invest $1,000 in NIKE Right Now?Before you consider NIKE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NIKE wasn't on the list.

While NIKE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Stoneridge, Inc. (SRI) Q4 2025 Earnings Call March 12, 2026 9:00 AM EDT

Company Participants

Kelly Harvey - Director of Investor Relations
James Zizelman - President, CEO & Director
Natalia Noblet - President of Electronics Division
Matthew Horvath - CFO & Treasurer
Robert Hartman - Chief Accounting Officer

Conference Call Participants

Gary Prestopino - Barrington Research Associates, Inc., Research Division

Presentation

Operator

Good morning, everyone, and welcome to the Stoneridge, Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please also note today's event is being recorded. At this time, I would like to turn the floor over to Kelly Harvey, Director of Investor Relations. Please go ahead.

Kelly Harvey
Director of Investor Relations

Good morning, everyone, and thank you for joining us to discuss our fourth quarter and full year 2025 results. The release and accompanying presentation was filed with the SEC and is posted on our website at stoneridge.com in the Investors section under Presentations and Events. Joining me on today's call are Jim Zizelman, our President and Chief Executive Officer; and Matt Horvath, our Chief Financial Officer. Also on today's call are Natalia Noblet, our President of Stoneridge Electronics and incoming Chief Executive Officer; and Bob Hartman, our Chief Accounting Officer, who will be stepping into the role of Interim Chief Financial Officer on April 1.

During today's call, we will be referring to certain non-GAAP financial measures. Please see Slide 2 of the presentation for a more detailed description of these non-GAAP measures and the appendix for a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures. In addition, certain statements today may be forward-looking statements. Forward-looking statements include statements that are not historical in nature and include information concerning our future results or plans. Although we believe that such statements are based upon reasonable assumptions, you should

CION Investment Corporation (CION) Q4 2025 Earnings Call March 12, 2026 11:00 AM EDT

Company Participants

Michael Reisner - Co-Founder, Co-Chairman & Co-CEO
Gregg Bresner - President & Chief Investment Officer
Keith Franz - MD, CFO & Treasurer

Conference Call Participants

Erik Zwick - Lucid Capital Markets, LLC, Research Division

Presentation

Operator

Good morning, and welcome to CION Investment Corporation's Fourth Quarter and Year-End 2025 Earnings Conference Call. Our earnings press release was distributed earlier this morning before market opened. A copy of the release, along with the supplemental earnings presentation is available on the company's website at www.cionbdc.com in the Investor Resources section and should be reviewed in conjunction with the company's Form 10-K filed with the SEC. As a reminder, this conference call is being recorded for replay purposes.

Please note that today's conference call may contain forward-looking statements, which are not guarantees of future performance or results and involve a number of risks and uncertainties.

Actual results may differ materially from those in the forward-looking statements as a result of numbers of factors, including those described in the company's filings with the SEC. Joining me on today's call will be Michael Reisner, CION Investment Corporation's Co-Chief Executive Officer; Gregg Bresner, President and Chief Investment Officer; and Keith Franz, Chief Financial Officer.

With that, I would like to turn the call over to Michael Reisner. Please go ahead, Michael.

Michael Reisner
Co-Founder, Co-Chairman & Co-CEO

Thank you, and good morning, everyone. Before I address our quarterly results, I want to step back for a moment and highlight what I believe is the most important takeaway from this quarter. We believe that our core first lien portfolio which represents approximately 81% of our investments continues to perform well.

Weighted average interest coverage across our portfolio increased quarter-over-quarter from 1.94x

Q4: 2026-03-11 Earnings SummaryEPS of -$0.20 misses by $0.13

 |

Revenue of

$165.84M

(-29.37% Y/Y)

misses by $24.72M

HighPeak Energy, Inc. (HPK) Q4 2025 Earnings Call March 12, 2026 11:00 AM EDT

Company Participants

Steven Tholen - Chief Financial Officer
Michael Hollis - President, CEO, & Director
Ryan Hightower - VP of Business Development

Conference Call Participants

Noah Hungness - BofA Securities, Research Division
Jeffrey Robertson - Water Tower Research LLC

Presentation

Operator

Good day, and thank you for standing by. Welcome to the HighPeak 2025 Fourth Quarter Earnings Conference Call. [Operator Instructions]. Please be advised today's conference is being recorded. I would now like to hand the conference over to your speaker today, Steven Tholen, CFO. Please go ahead.

Steven Tholen
Chief Financial Officer

Good morning, everyone, and welcome to HighPeak Energy's earnings call. Representing HighPeak today are President and CEO, Michael Hollis; Executive Vice President, Ryan Hightower; Executive Vice President, Daniel Silver; Senior Vice President, Chris Munday, and I am Steven Tholen, the Chief Financial Officer. During today's call, we may refer to our March investor presentation and press release, which can be found on HighPeak's website.

Today's call participants may make certain forward-looking statements relating to the company's financial condition, results of operations, expectations, plans, goals, assumptions and future performance. So please refer to the cautionary information regarding forward-looking statements and related risks in the company's SEC filings, including the fact that actual results may differ materially from our expectations due to a variety of reasons, many of which are beyond our control. We will also refer to certain non-GAAP financial measures on today's call, so please see the reconciliations in the earnings release and in our March investor presentation.

I will now turn the call over to our President and CEO, Mike Hollis.

Michael Hollis
President, CEO, & Director

Thank you, Steve. Good morning, everyone, and thank you for joining us. I thought about kicking off things today by walking

HomeEarnings AnalysisHealthcare 

SummaryCodexis, Inc. delivered strong FY25 results, with revenue up 19% to $70.4M, driven by a $37.8M technology transfer agreement with Merck.CDXS’s ECO Synthesis platform targets the expanding siRNA/RNA therapeutics market, offering scalable, high-margin enzymatic manufacturing as a disruptive alternative to chemical synthesis.Operational improvements included gross margin expansion to 64%, narrowed net loss, and SG&A expense reductions, positioning CDXS for financial sustainability.CDXS stock's valuation remains modest at 1.76x forward EV/sales, reflecting execution risk; further upside depends on scaling ECO Synthesis adoption and securing more licensing deals. mphillips007/iStock via Getty Images

Thesis Codexis, Inc. (CDXS) has just reported a pretty strong end-of-year financial result. Revenue hit $38.9 million for the quarter, up about 81% year-over-year, and beat the consensus by about $3.1 million. Revenue was mainly helped out by a technology

1.06K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Key Takeaways IRWD expects 2026 revenues of $450-$475M, up 54% Y/Y at midpoint, on high Linzess demand.Ironwood plans a confirmatory phase III study of apraglutide in SBS-IF starting later in 2026.PBYI posted $204.1M Nerlynx sales in 2025 as demand grew, but issued a weaker-than-expected 2026 outlook. Ironwood Pharmaceuticals (IRWD - Free Report) and Puma Biotechnology (PBYI - Free Report) are small-cap biotech firms that depend largely on the successful commercialization of a single key drug while trying to broaden their relatively limited pipelines. Each company continues to rely heavily on its marketed product as it aims to build a strong presence in its respective therapeutic area.

While Ironwood is more focused on its key gastrointestinal (GI) disorder drug and a pipeline targeting rare GI conditions, Puma Biotechnology is a cancer biotech focused on developing therapies targeting breast cancer and other tumor types.

But which one makes for a better investment pick today? Let's examine the fundamentals of the two stocks to make a prudent choice.

The Case for IRWD StockIronwood’s sole marketed product, Linzess (linaclotide), is approved for the treatment of irritable bowel syndrome with constipation (IBS-C) and functional constipation.

Ironwood markets Linzess in the United States in collaboration with drug giant AbbVie (ABBV - Free Report) . The companies equally share Linzess’ brand collaboration profits and losses in the United States.

Ironwood’s top line primarily comprises revenues recorded under its collaborative arrangements with ABBV for the development and commercialization of Linzess in the United States.

Despite gaining momentum in recent times, Linzess sales were soft during the fourth quarter of 2025. Management noted that the decline in Linzess sales was largely due to gross-to-net rebate adjustments and higher pricing pressure from the Medicare Part D redesign, and not underlying demand during this time.

Although Ironwood’s share of net profit from the sales of Linzess in the United States declined 15% year over year in 2025, Linzess’ prescription demand remained strong during this period, underscoring management’s optimism for sustained growth in 2026. Ironwood is also focusing on Linzess’ label expansion efforts to support long-term growth.

Building on this momentum, Ironwood expects a strong rebound and improvement in Linzess’ sales in 2026 and subsequently its share of net profit from the sales of the drug in the United States. Ironwood expects total revenues of $450-$475 million in 2026. The revenue outlook for 2026 indicates an increase of 54% year over year at the midpoint compared with 2025.

Ironwood is developing its next-generation GLP-2 analog, apraglutide, for treating patients with short bowel syndrome (“SBS”) with intestinal failure (“IF”) who are dependent on parenteral support (“PS”). The company recently met with the FDA and aligned on key elements of a confirmatory phase III study design, which will evaluate apraglutide in patients with SBS-IF. Initiation of clinical sites for the study is expected to begin in the second quarter of 2026.

Despite the encouraging outlook, Ironwood’s heavy reliance on a single product remains a concern. Additionally, any delay or setback in the development of apraglutide could weigh on its near-term growth prospects as 2026 progresses.

The Case for PBYI StockPuma Biotechnology’s sole marketed product, Nerlynx, is approved for treating early-stage HER2-positive breast cancer in patients previously treated with Herceptin-based adjuvant therapy. The drug is also approved in combination with Xeloda (capecitabine) for treating certain patients with advanced or metastatic HER2-positive breast cancer.

Nerlynx sales rose 4.5% on a year-over-year basis to $204.1 million in 2025. Sales of the drug have been rising owing to increasing demand in the United States. The company expects continued demand-driven growth in Nerlynx sales in 2026.

However, despite the increasing demand for Nerlynx, Puma Biotechnology issued a weaker-than-expected 2026 financial outlook last month. The guidance reflected a more cautious growth path for Nerlynx, suggesting a more conservative pace of near-term adoption for the product.

For full-year 2026, total revenues are expected in the range of $214-$221 million, while net product revenues from Nerlynx sales are projected to be between $194 million and $198 million.

PBYI is developing its pipeline candidate, alisertib, an aurora kinase A inhibitor, in separate mid-stage studies for treating hormone receptor-positive breast cancer as well as small-cell lung cancer. Interim data readouts from these studies are expected to be announced in the second quarter of 2026. Per management, the successful development of the candidate is likely to enhance the company’s position in the anti-cancer drug market.

While the breast cancer market offers strong commercial potential, Puma Biotechnology remains highly dependent on Nerlynx for revenue growth, making it vulnerable to any regulatory setbacks. The drug’s sales have also declined in some past quarters due to weaker demand. Although sales are recovering, any similar slowdown in the future could weigh on the company’s prospects. Intense competition from established players in the market also remains a challenge.

How Do Estimates Compare for IRWD & PBYI?The Zacks Consensus Estimate for Ironwood’s 2026 earnings per share (EPS) implies a year-over-year increase of around 533%. EPS estimates for 2026 have been trending upward, while loss per share estimates for 2027 have been stable over the past 60 days.

IRWD Estimate Movement
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Puma Biotechnology’s 2026 EPS implies a year-over-year decrease of 36%. EPS estimates for 2026 and 2027 have been trending downward over the past 60 days.

PBYI Estimate Movement
Image Source: Zacks Investment Research

Price Performance and Valuation of IRWD & PBYIYear to date, shares of IRWD have increased 9.2%, while those of PBYI have risen 0.8%. In comparison, the industry has declined 0.4%, as seen in the chart below.

Image Source: Zacks Investment Research

Ironwood looks more expensive than Puma Biotechnology, going by the price-to-sales (P/S) ratio. IRWD’s shares currently trade at 2.02 times trailing sales value, higher than 1.35 for PBYI.

Image Source: Zacks Investment Research

IRWD vs. PBYI: Which Stock Holds the Edge?Ironwood has a Zacks Rank #3 (Hold), while Puma Biotechnology currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

For investors looking for a small-cap biotech stock with steady earnings momentum and growth potential, Ironwood looks like a better pick over Puma Biotechnology, based on the above discussion.

Though Nerlynx sales have been rising on the back of underlying demand, Ironwood’s recent approach of strengthening the Linzess franchise while progressing apraglutide, which holds blockbuster potential, positions it for long-term growth and profitability. Also, Puma Biotechnology’s high reliance on a single cancer drug and a muted 2026 outlook underscore the company’s vulnerability to regulatory and competitive risks.

Despite a premium valuation, Ironwood’s recent price rally and steady earnings estimates also indicate analysts' optimistic outlook for the stock. The robust financial outlook for 2026 also gives it an edge over Puma Biotechnology.

Overall, IRWD offers a clearer growth outlook, making it a better pick than PBYI for investors seeking meaningful gains in both the short and long term.

iShares MSCI Singapore ETF is rated a Buy, leveraging Singapore's aggressive AI adoption and strong governance as a forward-looking growth catalyst. Singapore's government-driven AI initiatives, including tax incentives and workforce upskilling, have propelled AI adoption from 24% in 2023 to 66% by 2025. EWS offers attractive fundamentals: a low ~15.3 P/E, ~2.3 P/S, a 0.5% expense ratio, and a >4% dividend yield, despite sector concentration in financials.

Key Takeaways BR gained 5.4% in a month, outperforming the industry's 2.9% growth.BR benefits from SaaS-based BPO services, DLR platform adoption and revenues from Canton Coin.BR expands via Acolin & iJoin buyouts while advancing digital assets & AI tools for governance. Shares of Broadridge Financial Solutions (BR - Free Report) have had a decent run over the past month. The stock has gained 5.4%, outpacing the industry’s 2.9% growth.

BR has a Growth Score of B. This style score condenses key financial metrics to reflect a fair sense of the quality and sustainability of its growth.

The company’s third-quarter fiscal 2026 earnings are expected to be up 7.8% year over year. Earnings for fiscal 2026 and 2027 are projected to rise 10.6% and 9.7%, respectively, year over year. Revenues are expected to increase 6.6% in fiscal 2026 and 4.4% in fiscal 2027.

Factors That Bode Well for BRBR is benefiting from revenue growth driven by its Software-as-a-Service (SaaS)-based BPO services, leveraging networks, data and digital capabilities. The company’s diversified products and services, along with acquisitions, support top-line growth, enabling it to gain more market share.

The company’s top line benefits from balanced demand in its capital markets business. Growing adoption of BR’s DLR platform, a distributed ledger repo platform, and revenues from Canton Coin, a utility token used to pay application and infrastructure fees on the Global Synchronizer, collectively drive growth in this segment. Broadridge completed the issuance of SOC GENS’ (France's financial institution) first digital bond, highlighting the flexibility and power of its DLR platform to tokenize a wide range of assets.

Broadridge continues to drive democratization and digitization in the governance business to boost demand for U.S. equities, banking on its shareholder rights protection characteristics. It is also rolling out an AI-native policy engine and vote implementation capabilities for institutional investors like JPMorgan and Wells Fargo to reduce their reliance on proxy advisers.

BR continues to build its pilot program, earlier launched with ExxonMobil, to enable retail shareholders to provide standing voting instructions for annual meetings. The company also expects to integrate tokenized and digital assets into its proxy capabilities and extend them to digital wallets where investors hold their equities and other tokenized assets, creating a seamless client experience by the end of 2026.

BR is also investing in acquisitions to accelerate its product set and development, domestically and internationally. In January 2026, the company acquired Acolin, a European provider of cross-border fund distribution and regulatory services, to expand its distribution solutions for asset managers, helping them enter new markets and grow assets, while also strengthening its regulatory services for the global asset management industry.

In September 2025, the company acquired iJoin, a retirement plan technology provider specializing in participant onboarding, engagement and analytics solutions, to strengthen its workplace and retirement solutions business.

Broadridge consistently rewards its shareholders through dividend payments. In fiscal 2022, 2023, 2024 and 2025, the company paid out $290.7 million, $331 million, $368.2 million and $402.3 million in dividends, respectively. Such moves boost shareholder value and instill investor confidence.

A Risk to WatchBR had a current ratio of 0.97 at the end of the second quarter of fiscal 2026, lower than the industry's average of 2.1. A current ratio below 1 often suggests that a company may not be well-positioned to meet its short-term obligations.

BR currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Stocks to ConsiderA couple of better-ranked stocks in the industry are Autodesk, Inc. (ADSK - Free Report)  and HubSpot, Inc. (HUBS - Free Report) .

Autodesk currently carries a Zacks Rank #2 (Buy). It has a long-term earnings growth expectation of 16.2%.

ADSK delivered an average trailing four-quarter earnings surprise of 7.5%.

HubSpot also holds a Zacks Rank of 2 at present, with a long-term earnings growth expectation of 18.6%.

HUBS delivered a trailing four-quarter earnings surprise of 3% on average.

, /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, and Yamaha Motor Co. have co-developed an innovative airbag system for the new Tricity 300 commuter scooter. This is a significant step toward making advanced safety solutions accessible to a wider range of riders, moving beyond their previous availability solely on high-end motorcycles. The collaboration reflects Autoliv's continued expansion beyond its core business and supports the company's long-term strategic direction.

The unpredictable nature of motorcycle crashes underscores the need for a holistic approach to safety. This new airbag system is designed to protect the rider in the event of a front collision.

"This collaboration represents a key development beyond our core business. It contributes to our future growth, and it is an important step in delivering on our long-term strategic agenda. It also marks a significant advancement in safeguarding motorcyclists, who traditionally have far less protection than occupants in light vehicles." said Mikael Bratt, President & CEO, Autoliv.

As a leader in automotive safety, Autoliv is committed to advancing innovative solutions that protect all road users, and this new motorcycle airbag system is a significant step forward of that ambition.

The airbag is seamlessly integrated into the panel of the motorcycle and engineered to absorb the rider's kinetic energy in a frontal collision while maintaining vehicle balance and storage space. To achieve high levels of performance and reliability, the product has undergone validation consistent with applicable development standards, including advanced simulations and full-scale crash testing.

The updated Tricity 300 model is expected to be available on the market during the first half of 2026, featuring an airbag module supplied by Autoliv.

To explore the technical specifications of this safety innovation, please visit Autoliv's website  for more information.

Press images: Autoliv Media Gallery

Inquiries: 

Media: [email protected]

Gabriella Etemad, Tel +46 70 612 64 24, Emelie Ericson, Tel +46 70 957 81 35

Investors & Analysts: [email protected]

Anders Trapp, Tel +46 709 578 171, Henrik Kaar, Tel +46 709 578 114

About Autoliv

Autoliv, Inc. (NYSE: ALV; Nasdaq Stockholm: ALIV.sdb) is the worldwide leader in automotive safety systems. Through our group companies, we develop, manufacture and market protective systems, such as airbags, seatbelts, and steering wheels for all major automotive manufacturers in the world, as well as mobility safety solutions, such as commercial vehicles and electrical safety solutions. At Autoliv, we challenge and re-define the standards of mobility safety to sustainably deliver leading solutions. In 2025, our products saved approximately 40,000 lives and reduced around 600,000 injuries.

We have operations in 25 countries, and we drive innovation, research, and development at our 13 technical centers. Our 65,000 employees are passionate about our vision of Saving More Lives and quality is at the heart of everything we do. Sales in 2025 amounted to $10.8 billion. For more information go to www.autoliv.com.

Safe Harbor Statement

This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements, including general economic conditions and fluctuations in the global automotive market. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any such statements in light of new information or future events, except as required by law.

CONTACT:

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/autoliv/r/autoliv-and-yamaha-motor-introduce-airbag-for-commuter-scooter,c4320431

The following files are available for download:

SOURCE Autoliv

Q1: 2026-03-12 Earnings SummaryEPS of -$0.01 beats by $0.02

 |

Revenue of

$8.83M

(14.70% Y/Y)

beats by $18.00K

GURU Organic Energy Corp. (GURU:CA) Q1 2026 Earnings Call March 12, 2026 10:00 AM EDT

Company Participants

Carl Goyette - President, CEO & Director
Ingy Sarraf - COO, CFO & Corporate Secretary

Conference Call Participants

Martin Landry - Stifel Nicolaus Canada Inc., Research Division
Sean McGowan - ROTH Capital Partners, LLC, Research Division

Presentation

Operator

Welcome to the GURU Organic Energy First Quarter 2026 Results Conference Call and Webcast being recorded today, March 12, 2026, at 10:00 a.m. Eastern Time. [Operator Instructions] GURU's press release, MD&A and financial statements are available in the Investors section of its website and on SEDAR+.

During the call, the company may refer to certain non-GAAP measures. Reconciliations are available in its MD&A. Also note that all financial figures are expressed in Canadian dollars, unless otherwise indicated.

I would also like to remind you that today's presentation may contain forward-looking statements about GURU's current and future plans, expectations and intentions, results, level of activity, performance, goals or achievements or other future events or developments. Please take a moment to read the disclaimer on forward-looking statements on Slide 2 of the presentation.

I would now like to turn the call over to Carl Goyette, GURU's Chief Executive Officer.

Carl Goyette
President, CEO & Director

Thank you, operator. [Foreign Language] Good morning, everyone, and welcome to GURU's Fiscal 2026 First Quarter Results Conference Call. Joining me this morning is our CFO, Ingy Sarraf.

Let's turn to Slide 5. Q1 2026 marks the third consecutive quarter of positive adjusted EBITDA and the strongest first quarter in GURU's history. We delivered record first quarter net revenue of $8.8 million, up 14.7% year-over-year. Gross margin expansion to 63%, up 345 basis points, and our first EBITDA positive Q1 since going public, achieved during our seasonally softer quarter. Over the last several quarters, we have clearly demonstrated our ability to execute and